Sakura Finetek Europe B.V.
Sakura Finetek Europe B.V. is a privately held Dutch medical device company that designs, manufactures, and services the Tissue-Tek portfolio of automated anatomic pathology instruments and consumables, serving hospital pathology departments and independent laboratories across 14 European countries through direct field sales.
- Company typePrivate
- Founded1871
- HeadquartersAlphen Aan Den Rijn, Netherlands
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Sakura Finetek Europe B.V. does
Sakura Finetek Europe B.V. is a privately held medical device company headquartered in Alphen aan den Rijn, Netherlands, that designs, manufactures, and services automated instrumentation for anatomic pathology laboratories across Europe. The company is the European arm of the Sakura Finetek group and operates through 14 wholly-owned subsidiaries covering Austria, Belgium, Denmark, France, Germany, Ireland, Italy, the Netherlands, Norway, Poland, Portugal, Spain, Sweden, and the United Kingdom, selling directly to hospital pathology departments and independent pathology laboratories via country-level Sales Managers, Application Specialists, and field service engineers. Its customers use its instruments to perform tissue processing, embedding, microtomy, staining, coverslipping, advanced immunohistochemistry (IHC) and in situ hybridisation (ISH) staining, and archiving, with the stated goal of achieving same-day diagnosis and reducing rework rates.
The company's product portfolio is built around the Tissue-Tek brand and unified under the SMART Automation concept, an end-to-end continuous-flow workflow. Core instruments include the Tissue-Tek Xpress x120 continuous rapid tissue processor (up to 120 cassettes/hour, 80% reagent waste reduction), the Tissue-Tek AutoTEC a120 automated embedder, the Tissue-Tek SmartConnect automated transfer system, the Tissue-Tek Prisma Plus and Film integrated staining and coverslipping system, the Tissue-Tek AutoSection microtome, and the Tissue-Tek Genie, described as the first and only fully automated true random-access IHC/ISH stainer with 30 independent slide stations and 130+ NordiQC-verified Ready-to-Use antibodies and probes. Supporting services include Sakura Bridge implementation consultancy, GenieOnline consumable replenishment, and Tissue-Tek iSupport remote monitoring.
Sakura generates revenue from four streams: one-time hardware sales of instruments, recurring consumables and reagents (Paraform cassettes, tissue orientation gels, paraffin wax, RTU antibody and probe capsules, detection kits), recurring Platinum, Gold, and Silver tier service and maintenance agreements, and recurring leasing solutions. Pricing is quote-based and not publicly disclosed. The company's positioning emphasises IVDR-ready compliance, continuous small-batch workflow versus traditional batch processing, and integration with digital pathology, including through a global alliance with Hamamatsu Photonics K.K. that links Sakura's slide preparation with photonics-based imaging.
Sakura Finetek Europe B.V. firmographics
Firmographics- Name
- Sakura Finetek Europe B.V.
- Legal name
- Sakura Finetek Europe B.V.
- Website
- https://sakura.eu
- Company type
- Private
- Founded year
- 1871
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Sakura Finetek Europe B.V. is a privately held Dutch medical device company that designs, manufactures, and services the Tissue-Tek portfolio of automated anatomic pathology instruments and consumables, serving hospital pathology departments and independent laboratories across 14 European countries through direct field sales.
- Ownership category
- akta.pro rank
Where Sakura Finetek Europe B.V. is headquartered
LocationHeadquarters
- HQ city
- Alphen Aan Den Rijn
- HQ country
- Netherlands
- HQ region
- Europe
Offices14 records
Markets served
Sakura Finetek Europe B.V. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Medical instrument hardware sales: Sale of automated pathology instruments including Tissue-Tek Xpress x120, AutoTEC a120, SmartConnect, Prisma Plus, and Genie systems. Instruments are sold directly to pathology laboratories and hospitals.
- Consumables and reagents: Recurring revenue from consumables including Tissue-Tek Paraform Cassettes, Paraform Tissue Orientation Gels, Paraffin Wax, ready-to-use antibody and probe capsules for the Genie system, DAB/AP Red/DUO detection kits. Consumables are replenished via the GenieOnline platform.
- Service and maintenance agreements: Platinum, Gold, and Silver tier service agreements providing preventive maintenance, technical support, and uptime guarantees for instruments. Also includes user training services (ISO 15189 accredited) and express delivery of spare parts and consumables.
- Leasing solutions: Leasing arrangements allowing laboratories to access the latest instrumentation without high-capital investment, addressing day-to-day operational challenges.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Platinum Service Agreement |
| Other | Multi-year contract | Gold Service Agreement |
| Other | Multi-year contract | Silver Service Agreement |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Sakura Finetek Europe B.V. product offering
Product offeringCore offering
Sakura Finetek Europe manufactures and sells the Tissue-Tek line of automated anatomic pathology instruments and consumables covering the complete tissue diagnostic workflow — grossing/identification, processing, transferring, embedding, microtomy, staining and coverslipping, advanced IHC/ISH staining, and archiving. The portfolio is delivered as the integrated SMART Automation platform combining the Xpress x120 rapid tissue processor, AutoTEC a120 embedder, SmartConnect robotic transfer, Prisma Plus & Film staining/coverslipping, and the Genie IHC/ISH stainer, supported by Sakura Bridge implementation consultancy, GenieOnline inventory platform, and iSupport remote monitoring, plus recurring consumables such as Paraform Cassettes, Tissue Orientation Gels, and Paraffin Wax.
Product overview
Sakura Finetek Europe B.V. offers an integrated portfolio of Tissue-Tek branded instruments and services for anatomic pathology laboratories, covering the complete tissue journey from grossing/identification through processing, transferring, embedding, microtomy, staining/coverslipping, advanced staining, and archiving. The core platform is SMART Automation, a unified approach combining the Tissue-Tek Xpress x120 (continuous rapid tissue processor), Tissue-Tek AutoTEC a120 (automated embedder), Tissue-Tek SmartConnect (automated transfer), Tissue-Tek Prisma Plus and Film (staining and coverslipping), and Tissue-Tek Genie (advanced IHC/ISH stainer). Supporting services include Sakura Bridge (implementation consultancy), GenieOnline (inventory management), and Tissue-Tek iSupport (remote monitoring). The portfolio is designed to enable continuous workflow, same-day diagnosis, and digital pathology.
Differentiator
Problem solved
Functional benefit
Brands
- Sakura: Primary brand name used for the company's pathology automation solutions including Tissue-Tek product lines.
- SMART Automation
- Sakura Bridge
- Tissue-Tek
Products and services
- Tissue-Tek Xpress x120 Continuous Rapid Tissue Processor Automated continuous tissue processor that loads and processes up to 120 tissue cassettes per hour with continuous loading and 20-minute intervals between batch startups. Reduces reagent waste by 80% versus conventional processing. Used by pathology laboratories to enable continuous workflow and same-day diagnosis.
- Tissue-Tek AutoTEC a120 Automated Tissue Embedder Automated embedding system that produces up to 40 cassettes available for microtomy every 20 minutes. Features an integrated barcode reader for track-and-trace, and is compatible with Tissue-Tek Paraform Cassettes and Paraform Tissue Orientation Gels. Used by histology laboratories to automate manual embedding.
- Tissue-Tek SmartConnect Automated Tissue Transfer System Automated robotic system that loads cassettes with grossed tissue and unloads embedded blocks, automating the transfer step between grossing and embedding. Used by anatomic pathology laboratories to reduce manual handling and turnaround time.
- Tissue-Tek Genie Advanced Staining System First and only fully automated, true random-access stainer for immunohistochemistry (IHC) and in situ hybridisation (ISH). Features 30 self-contained independent slide stations, over 130 NordiQC-verified Ready-to-Use antibodies and probes, ready-to-use antibody capsules, and a standard 2-hour-45-minute turnaround time. Used by clinical and research pathology laboratories for standardised advanced staining.
- Tissue-Tek Prisma Plus and Tissue-Tek Film Integrated Staining and Coverslipping Combined tissue staining and film coverslipping system that delivers quality, speed, and reliability with slide preparation optimised for high-quality digital scanning and digital pathology workflows. Used by histopathology laboratories transitioning to digital pathology.
- Tissue-Tek AutoSection Automated microtomy solution providing precise and consistent sectioning of tissue blocks. Used by histology laboratories for standardised microtomy as part of the SMART Automation workflow.
- SMART Automation Platform Integrated end-to-end workflow automation platform spanning identification, processing, transferring, embedding, microtomy, staining/coverslipping, advanced staining, and archiving. Designed to achieve >95% same-day diagnosis and <1% rework through continuous small-batch flow rather than large batches. Sold to hospital and independent pathology laboratories as a unified platform.
- Sakura Bridge Implementation Consultancy Structured implementation consultancy guiding laboratories through every phase of automation adoption — opportunity analysis, planning, execution, and performance review — including change management, workflow optimisation, and accredited user training (ISO 15189). Sold as a service alongside SMART Automation instrument deployments.
- Tissue-Tek iSupport Remote Monitoring Remote monitoring service that allows Sakura field service engineers to diagnose instrument errors and identify required replacement parts proactively, supporting instrument uptime and operational continuity. Sold as part of multi-year service agreements to pathology laboratories operating Sakura instruments.
- GenieOnline Replenishment Platform Online platform for Tissue-Tek Genie customers providing automated consumable replenishment, inventory control, and daily operational oversight. Sold to laboratories operating the Genie IHC/ISH system.
- Platinum / Gold / Silver Service Agreements Tiered multi-year service agreements (Platinum, Gold, and Silver) providing preventive maintenance, technical support, and uptime guarantees for Sakura pathology instruments. Also include user training services (ISO 15189 accredited) and express delivery of spare parts and consumables. Sold to laboratories as ongoing support contracts.
- Tissue-Tek Paraform Cassettes Secure tissue orientation cassettes designed to minimise orientation errors and tissue sample loss from grossing through embedding. Sold as consumables to pathology laboratories using Sakura instruments.
- Tissue-Tek Paraform Tissue Orientation Gels Hydrogels designed to safely hold and maintain the orientation of small tissue samples during processing. Sold as consumables to pathology laboratories.
- Tissue-Tek Paraffin Wax 100% DMSO-free paraffin wax available in various sizes and temperature ranges for tissue processing. Sold as a recurring consumable to pathology laboratories.
Quantifiable outcome
- Same-day diagnosis rate of <95% with <1% rework
- +8 more outcomes
Companies that use Sakura Finetek Europe B.V.
Customer profileNamed customers12 records
Segments1 record
Ideal customer profiles1 record
Sakura Finetek Europe B.V. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature9 records
Sakura Finetek Europe B.V. partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Hamamatsu Photonics K.K.coreGlobal partnership between Sakura Finetek and Hamamatsu Photonics K.K. announced to strengthen the digital pathology workflow from slide preparation to imaging. This partnership combines Sakura's tissue processing and staining automation expertise with Hamamatsu's photonics imaging technology to create an integrated end-to-end digital pathology solution.
Scale indicators10 records
Recent moves6 records
Expansion highlights5 records
Sakura Finetek Europe B.V. competitors and assessment
Company assessmentDirect peers
- Roche Diagnostics (Ventana): Roche's Ventana product line is the dominant IHC/ISH staining platform, competing head-to-head with Sakura's Tissue-Tek Genie in hospital pathology labs.
- Dako (Agilent Technologies): Dako, owned by Agilent, is a major IHC/ISH and anatomic pathology reagent and instrument vendor with overlapping customer base in European hospital pathology labs.
- Epredia: Epredia (formerly Thermo Fisher's Anatomical Pathology business, now owned by PHC Holdings) supplies histology instruments, consumables, and reagents, overlapping directly with Sakura's Tissue-Tek portfolio.
- Leica Biosystems: Owned by Danaher, Leica Biosystems is one of the largest anatomic pathology instrument and reagent vendors globally, competing directly across histology processors, stainers, and IHC systems.
Others
- Bio-Techne: Reagent and assay provider with an IHC and tissue diagnostics product line that overlaps with Sakura's RTU antibody offering, though Bio-Techne is more research-focused.
- Hamamatsu Photonics: Strategic partner for digital pathology imaging; adjacent as a photonics/whole-slide imaging vendor with technology that complements Sakura's slide preparation workflow.
Broad incumbents
- Hologic: Broad diagnostics company with histology-adjacent capabilities; competes in the broader women's health and surgical pathology space rather than head-to-head with Sakura's histology automation.
- Thermo Fisher Scientific: Larger life sciences tools incumbent with adjacent pathology and laboratory instrument offerings; competes indirectly through scale and breadth even where it lacks Sakura's specialized automation depth.
- Merck KGaA (MilliporeSigma): Broad life science tools and consumables supplier with histology reagents and laboratory products that overlap with Sakura's reagent and consumable portfolio.
Emerging players
- 3DHISTECH: Digital pathology vendor offering whole-slide scanners and image management software, representing the digital pathology adjacency that Sakura's Hamamatsu partnership targets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Sakura Finetek Europe B.V. social profiles
Digital presenceSakura Finetek Europe B.V. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sakura Finetek Europe B.V. leadership team
Management profileNumber of profiles
Sakura Finetek Europe B.V. subsidiaries and ownership
Company hierarchySubsidiaries14 records
Sakura Finetek Europe B.V. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sakura Finetek Europe B.V. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sakura Finetek Europe B.V.
What does Sakura Finetek Europe B.V. do?
Sakura Finetek Europe manufactures and sells the Tissue-Tek line of automated anatomic pathology instruments and consumables covering the complete tissue diagnostic workflow — grossing/identification, processing, transferring, embedding, microtomy, staining and coverslipping, advanced IHC/ISH staining, and archiving. The portfolio is delivered as the integrated SMART Automation platform combining the Xpress x120 rapid tissue processor, AutoTEC a120 embedder, SmartConnect robotic transfer, Prisma Plus & Film staining/coverslipping, and the Genie IHC/ISH stainer, supported by Sakura Bridge implementation consultancy, GenieOnline inventory platform, and iSupport remote monitoring, plus recurring consumables such as Paraform Cassettes, Tissue Orientation Gels, and Paraffin Wax.
Is Sakura Finetek Europe B.V. a public or private company?
Sakura Finetek Europe B.V. is a private company. It is classified as corporate owned and is currently operating.
When was Sakura Finetek Europe B.V. founded?
Sakura Finetek Europe B.V. was founded in 1871. It employs 251 to 500 people.
Where is Sakura Finetek Europe B.V. based?
Sakura Finetek Europe B.V. is headquartered in Alphen Aan Den Rijn, Netherlands, in the Europe region.
How does Sakura Finetek Europe B.V. make money?
Four revenue lines are on record. Medical instrument hardware sales are the primary driver. The others are consumables and reagents, service and maintenance agreements and leasing solutions.
Who are Sakura Finetek Europe B.V.'s main competitors?
Direct peers on record are Roche Diagnostics (Ventana), Dako (Agilent Technologies), Epredia and Leica Biosystems. Others are Bio-Techne and Hamamatsu Photonics. Broad incumbents are Hologic, Thermo Fisher Scientific and Merck KGaA (MilliporeSigma). 3DHISTECH is listed as an emerging player.
Does Sakura Finetek Europe B.V. have an API?
No public API is recorded for Sakura Finetek Europe B.V..